| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥11282.2B | ¥10790.6B | +4.6% |
| Operating Income | ¥763.3B | ¥626.9B | +21.8% |
| Ordinary Income | ¥875.1B | ¥797.2B | +9.8% |
| Net Income | ¥873.3B | ¥1179.2B | -25.9% |
| ROE | 7.2% | 9.8% | - |
FY2025 Q3 cumulative results showed mixed performance with revenue of 1,128.2 billion yen (YoY +4.6%), operating income of 76.3 billion yen (YoY +21.8%), ordinary income of 87.5 billion yen (YoY +9.8%), and net income of 87.3 billion yen (YoY -25.9%). The company achieved the second consecutive period of operating income growth, with operating margin improving to 6.8% from 5.8% in the prior year. The net income decline was primarily driven by extraordinary items comparison, as the current period recorded gain on sale of securities of 44.5 billion yen compared to significantly higher extraordinary gains in the prior year. Gross profit margin stood at 24.3% while SG&A expense ratio was 17.6% of revenue.
Revenue increased 4.6% YoY to 1,128.2 billion yen, driven by growth across all three reporting segments. SmartCommunication segment revenue grew 5.4% to 550.7 billion yen, LifeAndHealthcare segment increased 4.2% to 390.5 billion yen, and Electronics segment expanded 2.9% to 188.9 billion yen. The revenue growth was supported by sustained demand across business lines and operational improvements.
Operating income increased substantially by 21.8% YoY to 76.3 billion yen, with operating margin improving 1.0 percentage point to 6.8%. This profit expansion was achieved through gross profit growth of 5.2% to 274.6 billion yen and controlled SG&A expense growth. All three segments contributed to profit improvement, with LifeAndHealthcare showing particularly strong segment profit growth of 69.9% YoY. The ordinary income growth of 9.8% to 87.5 billion yen was supported by equity method income of 9.3 billion yen and net non-operating contributions of approximately 11.2 billion yen.
Net income declined 25.9% YoY to 87.3 billion yen despite operating profit growth. This decline was primarily driven by extraordinary items comparison, as the prior period contained significantly larger gains. The current period recorded extraordinary income of 45.1 billion yen including gain on sale of securities of 44.5 billion yen, while extraordinary losses totaled 5.9 billion yen including impairment loss of 0.9 billion yen. The effective tax rate of 31.1% on profit before tax of 126.8 billion yen resulted in income tax expense of 39.5 billion yen. This represents a revenue up, profit down pattern at the net income level, though operating profit showed strong improvement.
SmartCommunication is the largest segment accounting for 48.8% of total revenue with 550.7 billion yen, generating segment profit of 26.5 billion yen with a margin of 4.8%. The segment achieved revenue growth of 5.4% YoY and segment profit increased 29.8% YoY, indicating improving operational efficiency. LifeAndHealthcare contributed 390.5 billion yen in revenue (34.6% share) with segment profit of 28.5 billion yen and margin of 7.3%, representing the highest profitability among segments. This segment demonstrated strong momentum with revenue growth of 4.2% and segment profit growth of 69.9% YoY. Electronics segment generated 188.9 billion yen in revenue (16.7% share) with segment profit of 41.6 billion yen, achieving the highest margin of 22.0% among all segments, establishing it as the most profitable business on a margin basis. Electronics revenue grew 2.9% while segment profit decreased 2.4% YoY. The segment profit adjustment of negative 2.0 billion yen represents costs for basic research and shared research activities not attributable to specific segments.
[Profitability] ROE of 7.2% remained below the manufacturing industry median of 5.8%, indicating relative strength. Operating margin improved to 6.8% from 5.8% YoY, though remaining below the industry median of 8.9%, suggesting room for efficiency improvement. Net profit margin of 7.7% exceeded the industry median of 6.5%. [Cash Quality] Cash and deposits of 270.8 billion yen provided coverage of 0.71x against current liabilities of 383.4 billion yen. Receivables turnover stood at 109 days based on trade receivables of 336.6 billion yen, which is longer than the industry median of 85 days. [Investment Efficiency] Asset turnover of 0.57x aligned with industry median of 0.56x. Financial leverage of 1.63x was slightly above industry median of 1.53x. [Financial Health] Equity ratio of 61.5% was positioned near the industry median of 63.8%, indicating solid capitalization. Current ratio of 223.5% substantially exceeded the industry median of 287%, demonstrating strong short-term liquidity. The company maintained low interest-bearing debt of 50.9 billion yen consisting of 28.5 billion yen in short-term debt and 22.4 billion yen in long-term debt.
Cash and deposits increased 13.1% YoY to 270.8 billion yen, reflecting accumulated earnings and cash generation. Working capital showed mixed signals with trade receivables increasing 2.9% to 336.6 billion yen while trade payables grew 4.4% to 220.1 billion yen, indicating moderate supplier financing utilization. Inventory increased 7.1% to 89.6 billion yen including finished goods of 89.6 billion yen, raw materials of 45.2 billion yen, and work in process of 43.9 billion yen. The cash position relative to short-term liabilities stood at 0.71x, supplemented by investment securities of 369.0 billion yen which increased substantially by 29.6% YoY, providing significant financial flexibility. Long-term assets expanded with property, plant and equipment reaching 425.6 billion yen, indicating ongoing capital investment. The balance sheet structure suggests a shift toward strategic investments with goodwill increasing to 31.2 billion yen and intangible assets growing to 74.7 billion yen.
Ordinary income of 87.5 billion yen compared to operating income of 76.3 billion yen shows net non-operating contribution of approximately 11.2 billion yen. This comprised equity method income of 9.3 billion yen and net financial income. Non-operating expenses included interest expense of 1.9 billion yen and other non-operating expenses of 4.6 billion yen, while non-operating income totaled 17.7 billion yen. The extraordinary income of 45.1 billion yen primarily consisting of gain on sale of securities of 44.5 billion yen represents a non-recurring benefit accounting for 4.0% of revenue. Profit before tax reached 126.8 billion yen through the combination of ordinary income and net extraordinary gains of 39.6 billion yen. The income tax expense of 39.5 billion yen reflects an effective tax rate of 31.1%. The comprehensive income of 65.8 billion yen was impacted by valuation loss on securities of 12.8 billion yen, remeasurements of defined benefit plans of negative 8.1 billion yen, and foreign exchange translation adjustment of negative 0.9 billion yen, indicating mark-to-market impacts on the balance sheet.
The company revised its full-year forecast with revenue guidance of 1,515.0 billion yen (YoY +3.9%), operating income of 103.0 billion yen (YoY +10.0%), and ordinary income of 116.0 billion yen (YoY +0.1%). Progress rate through Q3 stood at 74.4% for revenue, 74.1% for operating income, and 75.4% for ordinary income, all tracking ahead of the standard 75% threshold for nine-month cumulative periods. The forecast implies Q4 revenue of 386.8 billion yen and operating income of 26.7 billion yen, representing sequential moderation. The guidance assumes basic EPS of 226.57 yen for the full year and annual dividend of 22.00 yen per share. The company implemented a 2-for-1 stock split effective October 1, 2024, with the year-end dividend of 22.00 yen reflecting post-split terms, equivalent to 44.00 yen pre-split for a total annual dividend of 76.00 yen on a pre-split basis.
Annual dividend is projected at 54.00 yen per share on a post-split basis, comprising interim dividend of 32.00 yen and year-end dividend of 22.00 yen, equivalent to 76.00 yen pre-split. Based on net income of 87.3 billion yen for the nine-month period and shares outstanding of 524.5 million shares, the payout ratio on trailing earnings approximates 33.2%, indicating a conservative and sustainable dividend policy. The increase in treasury stock to negative 174.0 billion yen from negative 135.3 billion yen in the prior year (an increase in treasury holdings of 38.7 billion yen) suggests active share repurchase activity during the period, enhancing total shareholder returns. The combined capital allocation through dividends and buybacks demonstrates a balanced approach to returning cash to shareholders while maintaining financial flexibility for growth investments.
Working capital efficiency presents operational risk with accounts receivable turnover of 109 days significantly exceeding the industry median of 85 days, indicating potential collection delays and cash conversion pressure. This extended collection period ties up approximately 336.6 billion yen in receivables. Strategic integration risk stems from substantial increases in goodwill to 31.2 billion yen (up 203%) and intangible assets to 74.7 billion yen (up 61%), suggesting recent acquisition activity that carries execution risk and potential future impairment exposure. Financial structure risk arises from short-term liabilities comprising 56% of total liabilities at 383.4 billion yen, creating refinancing exposure despite adequate liquidity coverage, as concentrated near-term obligations require active liability management and potential rollover of commercial commitments.
[Industry Position] (Reference - Proprietary Analysis) The company's profitability metrics show mixed positioning within the manufacturing sector. ROE of 7.2% exceeds the industry median of 5.8%, ranking in the upper tier of sector participants. Operating margin of 6.8% trails the industry median of 8.9%, suggesting operational efficiency improvement opportunities relative to peers. Net profit margin of 7.7% surpasses the industry median of 6.5%, indicating effective cost management at the net income level. The equity ratio of 61.5% aligns closely with the industry median of 63.8%, reflecting a balanced capital structure. Current ratio of 223.5% significantly underperforms the industry median of 287%, though still indicates adequate short-term liquidity. Asset turnover of 0.57x matches the industry median of 0.56x, demonstrating competitive asset utilization efficiency. Revenue growth of 4.6% YoY exceeds the industry median of 2.8%, positioning the company in the upper growth quartile. The receivables turnover of 109 days substantially exceeds the industry median of 85 days, representing a relative weakness in working capital management that warrants attention. (Industry: Manufacturing, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Operating leverage improvement is evident with operating income growth of 21.8% significantly outpacing revenue growth of 4.6%, demonstrating effective cost control and margin expansion as operating margin improved 1.0 percentage point to 6.8%. This operational improvement trend positions the company for enhanced profitability as revenue growth continues. Strategic investment cycle is underway with goodwill increasing 203% to 31.2 billion yen and intangible assets expanding 61% to 74.7 billion yen, coupled with treasury stock acquisition of 38.7 billion yen, indicating active capital deployment in both inorganic growth and shareholder returns that will shape medium-term performance trajectory. Working capital optimization represents a key earnings driver with receivables turnover of 109 days materially exceeding industry norms of 85 days, as improvement toward industry standards could release substantial cash and enhance return metrics, while the extended collection period currently constrains cash conversion efficiency despite strong profitability.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.